A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven®)

Home Treatment of Mild to Moderate Bleeding Episodes Using Recombinant Factor VIIa (Novoseven) in Haemophiliacs with Inhibitors

1998 • 362 citations

The Treatment of Bleeding in Acquired Haemophilia with Recombinant Factor VIIa: A Multicentre Study

1997 • 356 citations

The effect of fibrin structure on fibrinolysis.

1992 • 269 citations

Fibrin in human plasma: Gel architectures governed by rate and nature of fibrinogen activation

1994 • 266 citations

Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII.

1998 • 244 citations

Thrombin Activatable Fibrinolysis Inhibitor and an Antifibrinolytic Pathway

2000 • 202 citations

Home treatment with recombinant activated factor VII in patients with factor VIII inhibitors: the advantages of early intervention

1999 • 136 citations

Clinical Use of Recombinant FVIIa (rFVIIa)

1998 • 134 citations

Pharmacokinetics of Recombinant Activated Factor VII (rFVIIa)

2000 • 123 citations

Acute Myocardial Infarction Following Administration of Recombinant Activated Factor VII (Novo Seven) in a Patient with Haemophilia A and Inhibitor

1999 • 113 citations

Efficacy and Safety of Recombinant Factor VIIa in the Prophylaxis of Bleeding in Various Surgical Procedures in Hemophilic Patients with Factor VIII and Factor IX Inhibitors

2000 • 112 citations

Feasibility of Using Recombinant Factor VIIa in Continuous Infusion

1996 • 108 citations

Feasibility of using recombinant factor VIIa in continuous infusion.

1996 • 105 citations

Clinical experience with activated factor VII: focus on safety aspects.

1998 • 89 citations

Experiences with continuous infusion of recombinant activated factor VII.

1998 • 70 citations

Acute hemarthroses: the benefits of early versus late treatment with recombinant activated factor VII

2000 • 63 citations

Altered hemostasis in pulmonary hypertension

1998 • 61 citations

Recombinant Factor VIIa Does not Induce Hypercoagulability In Vitro

1999 • 56 citations

Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors Experience in the Netherlands and Belgium.

1998 • 50 citations

Continuous Infusion of Recombinant Factor VIIa in Hemophilic Patients with Inhibitors: Safety, Monitoring, and Cost Effectiveness

2000 • 43 citations

Clinical update on the use of recombinant factor VII

1995 • 38 citations

The Treatment of Bleeding in Hemophilic Patients with Inhibitors with Recombinant Factor VIIa

2000 • 36 citations

Treatment of bleeding episodes in patients with hemophilia and an inhibitor: comparison of two treatment protocols with recombinant activated factor VII

2000 • 31 citations

The Continuous Infusion of Recombinant Activated Factor VIIa (rFVIIa) in Patients with Factor VIII Inhibitors Activates the Coagulation and Fibrinolytic Systems without Clinical Complications

2000 • 31 citations

Optimal care of inhibitor patients during surgery

1998 • 30 citations

Recombinant factor VIIa in continuous infusion during central line insertion in a child with factor VIII high‐titre inhibitor

1998 • 24 citations

Home treatment with recombinant activated factor VII: results from one centre.

1998 • 23 citations

Experience with continuous infusion of recombinant activated factor VII in the Asia-Pacific region

2000 • 14 citations